NCT06476197 2025-07-17
Exploratory Trial of SAT-003 in Cancer Cachexia Patients With Discontinued Chemotherapy
S-Alpha Therapeutics, Inc.
Phase NA Completed
Clinical Trials
12 trialsNCT04153019 2025-06-12
PSYCHO-EDUCATIONAL AND REHABILITATIVE INTERVENTION FOR CANCER CACHEXIA (PRICC)
Azienda USL Reggio Emilia - IRCCS
Phase NA Completed
NCT01614990 2024-03-20
Pilot Clinical Trial of Repeated Doses of Macimorelin to Assess Safety and Efficacy in Patients With Cancer Cachexia
Garcia, Jose M., MD, PhD
Phase 2 Completed
NCT04127981 2023-03-23
Medical Imaging of Cachexia
Olivia Newton-John Cancer Research Institute
Phase NA Unknown
NCT05264038 2023-03-20
A First in Human Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics Effects of OC514
Oncocross Co. Ltd.
Phase 1 Completed
NCT02072057 2019-02-28
Study of Ruxolitinib in the Treatment of Cachexia in Patients With Tumor-Associated Chronic Wasting Diseases.
Kantonsspital Aarau
Phase 2 Terminated
NCT02359123 2018-04-10
Cannabics Capsules as Treatment to Improve Cancer Related CACS in Advanced Cancer Patients
Cannabics Pharmaceuticals Inc.
Phase NA Completed
NCT00815685 2017-03-23
A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia
H. Lee Moffitt Cancer Center and Research Institute
Phase NA Completed
NCT02553187 2017-02-15
A Prospective, Randomized, Controlled, Multicenter Study of Kanglaite Injection for the Treatment of Cancer Cachexia
Zhejiang Kanglaite Pharmaceutical Co.Ltd
Phase 4 Unknown
NCT00267358 2013-09-02
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia.
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed
NCT00378131 2013-09-02
Placebo Controlled, Randomized Safety and Efficacy Study of RC-1291 in Cancer Anorexia/Cachexia
Helsinn Therapeutics (U.S.), Inc
Phase 2 Completed
NCT00329615 2009-08-21
Insulin Treatment in Cancer Cachexia
Göteborg University
Phase 4 Completed